PF3D7_1412900

PF3D7_1412900 (Pf-Ubc9) is the SUMO E2-conjugating enzyme of Plasmodium falciparum, operating in a SUMOylation pathway that protects intraerythrocytic parasites against oxidative stress, as trophozoite-stage parasites become susceptible to iron-induced oxidative stress when SUMOylation is disrupted (PMID:26697886). Its engagement with the SUMO E1 activating enzyme is governed by species-specific surface residues: structural analysis of the human SUMO E1–E2 interface guided identification of surface residues on the P. falciparum E1 and E2 enzymes that account for E1–E2 interactions distinct from the human system (PMID:26697886). The specificity of SUMO–E2 recognition is likewise species-restricted and unidirectional — Pf-SUMO interacts with human Ubc9, but human SUMO1 fails to interact with PF3D7_1412900, a selectivity dictated by critical N-terminal residues of Pf-Ubc9 together with surface-accessible aspartates of Pf-SUMO; mutating these N-terminal residues to their human counterparts restores electrostatic, π–π, and hydrophobic contacts and enables cross-species binding (PMID:35331687). Beyond these interaction determinants and the oxidative-stress phenotype, no further mechanistic detail for PF3D7_1412900 has been characterized in the available corpus.

1. 2015 High

   It was unknown what structural features distinguish the parasite SUMO conjugation machinery from the human system; solving the human E1–E2 interface and mapping it onto the parasite enzymes established that specific surface residues on Pf-E1 and PF3D7_1412900 underlie species-specific E1–E2 interactions.

   Evidence X-ray crystallography of the human SUMO E1–E2 complex with in silico modeling, mutagenesis, and in vitro biochemical assays on the P. falciparum enzymes

   PMID:26697886

   Open questions at the time

   • No direct crystal structure of PF3D7_1412900 itself was reported
   • Downstream SUMO substrates conjugated by Pf-Ubc9 not identified
   • Functional consequence of disrupting the specific E1–E2 interface in living parasites not tested
2. 2015 Medium

   The cellular role of the parasite SUMOylation pathway was unclear; linking pathway activity to survival under iron-induced oxidative stress established a protective function for SUMOylation in intraerythrocytic trophozoites.

   Evidence In vitro iron-induced oxidative stress assay coupled with biochemical characterization of SUMOylation activity

   PMID:26697886

   Open questions at the time

   • Single lab, single method linking pathway activity to the phenotype
   • The specific contribution of PF3D7_1412900 versus other pathway components not isolated genetically
   • SUMOylation targets responsible for oxidative-stress protection unknown
3. 2022 Medium

   Whether SUMO–E2 recognition is interchangeable across species was unresolved; demonstrating a unidirectional cross-species interaction and pinpointing the governing residues established that PF3D7_1412900 N-terminal residues and Pf-SUMO surface aspartates dictate binding specificity.

   Evidence Biochemical and biophysical binding assays with site-directed mutagenesis, including humanizing Pf-Ubc9 N-terminal residues to restore cross-species binding

   PMID:35331687

   Open questions at the time

   • Single lab study without independent confirmation
   • Physiological role of the SUMO–E2 specificity in parasite biology not tested in vivo
   • Whether altered specificity affects substrate conjugation not addressed

• The SUMO substrates conjugated by PF3D7_1412900 and the in vivo genetic requirement for the enzyme during the parasite life cycle remain unidentified.
• No SUMO substrate repertoire defined for PF3D7_1412900
• No genetic knockout or knockdown phenotype reported
• No structural model of PF3D7_1412900 itself in complex with Pf-SUMO or Pf-E1